Varex Imaging (NASDAQ:VREX) Updates Q1 Earnings Guidance

Varex Imaging (NASDAQ:VREX) updated its first quarter earnings guidance on Tuesday. The company provided EPS guidance of $(0.05)-$0.10 for the period, compared to the consensus EPS estimate of $0.02. The company issued revenue guidance of $195-215 million, compared to the consensus revenue estimate of $186.50 million. Varex Imaging also updated its Q1 2025 guidance to -0.050-0.100 EPS.

Varex Imaging Stock Up 6.9 %

Varex Imaging stock opened at $16.49 on Friday. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.89 and a current ratio of 3.34. The firm has a 50 day moving average price of $12.50 and a 200 day moving average price of $13.47. Varex Imaging has a fifty-two week low of $10.19 and a fifty-two week high of $21.50. The company has a market capitalization of $674.44 million, a PE ratio of -14.09 and a beta of 0.53.

Analyst Upgrades and Downgrades

Separately, B. Riley assumed coverage on shares of Varex Imaging in a research report on Friday, August 23rd. They set a “buy” rating and a $21.00 price target on the stock.

About Varex Imaging

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.